North Dakota SB2402 expands pharmacists' prescriptive authority and defines therapeutic substitution.
North Dakota SB2402 amends the state's pharmacy practice laws to expand pharmacists' prescriptive authority. The bill allows pharmacists to prescribe certain drugs and devices for specific conditions, including antimicrobial prophylaxis for Lyme disease, antiviral drugs for influenza, and drugs for travel-related conditions. It also permits pharmacists to prescribe devices such as inhalation spacers and diabetes testing supplies. The bill defines "therapeutic substitution" and outlines conditions under which a pharmacist may substitute a drug for a therapeutically equivalent drug.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.